Crizotinib and Visual loss
Result of checking the interaction of drug Crizotinib and disease Visual loss for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Cases of optic atrophy and optic nerve disorder leading to vision loss have been reported with the use of crizotinib. It is recommended to perform an ophthalmological evaluation consisting of best corrected visual acuity, retinal photographs, visual fields, optical coherence tomography (OCT) and other evaluations as appropriate for new onset of severe visual loss. Discontinue crizotinib in patients with new onset of severe visual loss. There is insufficient information to characterize the risks of resumption of crizotinib in patients with a severe visual loss; a decision to resume treatment with crizotinib should consider the potential benefits to the patient. Care should be exercised when prescribing crizotinib in these patients.
Crizotinib - utrata wzroku 
Crizotinib - perda visual 
Crizotinib - kehilangan visual 
Crizotinib - kehilangan penglihatan 
Crizotinib - perdita della vista 
Crizotinib - perte visuelle 
Crizotinib - Sehverlust 
Crizotinib - pérdida visual 
Crizotinib - потеря зрения 
Crizotinib - görsel kayıp 
Crizotinib - فقدان بصري 
Crizotinib - 视力减退